Stock Analysis
Globe Life (NYSE:GL) First Quarter 2024 Results
Key Financial Results
- Revenue: US$1.42b (up 7.2% from 1Q 2023).
- Net income: US$254.2m (up 14% from 1Q 2023).
- Profit margin: 18% (up from 17% in 1Q 2023). The increase in margin was driven by higher revenue.
- EPS: US$2.71 (up from US$2.32 in 1Q 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Globe Life EPS Misses Expectations
Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 2.9%.
Looking ahead, revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 6.1% growth forecast for the Insurance industry in the US.
Performance of the American Insurance industry.
The company's shares are up 20% from a week ago.
Risk Analysis
Before you take the next step you should know about the 2 warning signs for Globe Life (1 can't be ignored!) that we have uncovered.
Valuation is complex, but we're helping make it simple.
Find out whether Globe Life is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.
View the Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About NYSE:GL
Globe Life
Globe Life Inc., through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States.
Outstanding track record, undervalued and pays a dividend.